Show simple item record

dc.contributor.authorPrice, Larry R. ( Orcid Icon 0000-0001-6413-1286 )
dc.contributor.authorKirsch, Tracey B. ( )
dc.contributor.authorKuhn, John ( )
dc.contributor.authorMarksberry, Jeff ( )
dc.contributor.authorHaltiwanger, Steven G. ( )
dc.identifier.citationKirsch, T. B., Kuhn, J., Price, L. R., Marksberry, J., & Haltiwanger, S. G. (2019). A Novel Medical Device that Relieves Anxiety, Depression and Pain While Improving Sleep in a Population of Teachers. Journal of Depression and Anxiety, 8(2): 334.en_US

Objectives: This study was conducted to confirm the benefits of Alpha-Stim ® cranial electrotherapy stimulation (CES) technology as an effective non-drug treatment for anxiety, mood, sleep, and pain in teachers following a successful pilot study at the Leigh Academy, Dartford, United Kingdom. The second objective was to determine whether the new smartphone app was a reliable method of evaluating the effectiveness, based on the pilot study in the UK, other prior surveys, and more than 100 prospective research studies conducted on Alpha-Stim technology conducted from 1981 through 2019.

Methods: Thirty-five teachers (29 females and 6 males) in the Mineral Wells, Texas Independent School District, volunteered to participate in a study to reduce anxiety, depression, insomnia, and pain by passing a mild electric current with specific waveform characteristics through their brains via electrodes that clip on their ears. It was a six- week open-label design where participants tracked their progress using a new smartphone app to record their symptoms at least five days per week. The subjects were encouraged to use the device for 20-60 minutes any time of day and for any indication.

Results: The statistical analyses revealed highly significant (p values <0.001) for anxiety, depression, insomnia, and pain. The effect size Cohen's d values from a total of 237 treatments were greater than two standard deviations for all outcome measures indicating a high level of practical change from baseline to posttest supporting the capability of Alpha-Stim CES technology in reducing self-perceived symptoms and the ability to monitor progress on the Alpha-Stim app.

Conclusion: This treatment effect with Alpha-Stim cranial electrotherapy stimulation on anxiety, insomnia, depression, and pain was consistent with prior surveys and confirmed the precision of the new app in determining progress from a single treatment and a series of treatments.

dc.format.extent4 pages
dc.format.medium1 file (.pdf)
dc.sourceJournal of Depression and Anxiety, 2019, Vol. 8, No. 2, 334
dc.subjectCranial electrotherapy stimulationen_US
dc.subjectAlpha-Stim ®
dc.titleA Novel Medical Device that Relieves Anxiety, Depression and Pain While Improving Sleep in a Population of Teachersen_US
dc.rights.licenseThis is an open access article distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
txstate.departmentCounseling, Leadership, Adult Education, and School Psychology



This item appears in the following Collection(s)

Show simple item record